Showing results (11-20 of 109) with videos related to
Sort By:
Pageof 11
Pharmacoepidemiology and Drug Safety|September 12, 2015
More realistic power estimation for new user, active comparator studies: an empirical exampleMugdha Gokhale, John B Buse, Virginia Pate, et al.BMJ Open Diabetes Research & Care|January 21, 2020
Real-world evidence on sodium-glucose cotransporter-2 inhibitor use and risk of Fournier's gangreneJeff Yufeng Yang, Tiansheng Wang, Virginia Pate, et al.Scientific Reports|October 15, 2020
The comparative risk of acute kidney injury of vancomycin relative to other common antibioticsMartina Gaggl, Virginia Pate, Til Stürmer, et al.Pharmacoepidemiology and Drug Safety|May 13, 2022
Considerations for observational study design: Comparing the evidence of opioid use between electronic health records and insurance claimsJessica C Young, Nabarun Dasgupta, Til Stürmer, et al.Diabetes, Obesity & Metabolism|November 21, 2018
Impact of metformin use on the cardiovascular effects of dipeptidyl peptidase-4 inhibitors: An analysis of Medicare claims data from 2007 to 2015Matthew J Crowley, Mugdha Gokhale, Virginia Pate, et al.JAMA Psychiatry|June 9, 2017
Simultaneous Antidepressant and Benzodiazepine New Use and Subsequent Long-term Benzodiazepine Use in Adults With Depression, United States, 2001-2014Greta A Bushnell, Til Stürmer, Bradley N Gaynes, et al.Diabetes Care|April 6, 2018
The Risk of Acute Pancreatitis After Initiation of Dipeptidyl Peptidase 4 Inhibitors: Testing a Hypothesis of Subgroup Differences in Older U.S. AdultsJin-Liern Hong, John B Buse, Michele Jonsson Funk, et al.Journal of Geriatric Oncology|September 11, 2023
Prognosis of older adults with chronic lymphocytic leukemia: A Surveillance, Epidemiology, and End Results-Medicare cohort studyEmilie D Duchesneau, Ann Marie McNeill, William Schary, et al.Diabetes, Obesity & Metabolism|June 30, 2017
Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetesElizabeth M Garry, John B Buse, Jennifer L Lund, et al.Pharmacoepidemiology and Drug Safety|February 11, 2016
Comparison of diagnostic evaluations for cough among initiators of angiotensin converting enzyme inhibitors and angiotensin receptor blockersMugdha Gokhale, Cynthia Girman, Yong Chen, et al.Pageof 11